Chicago Partners Investment Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Chicago Partners Investment Group’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-500	Closed	-$19K	–	1115
2018 Q2	$19K	Buy	+500	New	+$19.1K	﹤0.01%	679
2016 Q3	–	Sell	-200	Closed	-$5K	–	508
2016 Q2	$5K	Hold	200	–	–	﹤0.01%	407
2016 Q1	$4K	Hold	200	–	–	﹤0.01%	395
2015 Q4	$10K	Hold	200	–	–	﹤0.01%	398
2015 Q3	$9K	Buy	200 +100	+100%	+$4.83K	0.01%	343
2015 Q2	$5K	Sell	100 -34	-25%	-$1.37K	﹤0.01%	404
2015 Q1	$4K	Buy	134 +34	+34%	+$1.17K	﹤0.01%	450
2014 Q4	$3K	Buy	+100	New	+$2.78K	﹤0.01%	492

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Chicago Partners Investment Group's PTLA Position: Q3 2018 in Review

Chicago Partners Investment Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2018, closing a stake of 500 shares — an estimated $19K sold.

Chicago Partners Investment Group first reported a position in PTLA in Q4 2014 and held it in 8 quarters. The position peaked at $19K in Q2 2018. 197 funds tracked by Wall St. Rank hold PTLA as of Q3 2018.

Chicago Partners Investment Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Chicago Partners Investment Group sold 500 Portola Pharmaceuticals, Inc. shares in Q3 2018, an estimated $19K.
Chicago Partners Investment Group first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 8 quarters.
Chicago Partners Investment Group's Portola Pharmaceuticals, Inc. position peaked at $19K in Q2 2018.
197 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2018.

Based on Chicago Partners Investment Group's 13F filing for Q3 2018, filed 5 Nov 2018.